EcoDrugPlus

Glutamate Ionotropic Receptor Nmda Type Subunit 2c

Ensembl ID : ENSG00000161509
Gene: GRIN2C
Gene Synonyms: GLUN2C,NMDAR2C
20 APIs:
12 Enzyme and pathways 7 Cross references
318 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Glutamate Ionotropic Receptor Nmda Type Subunit 2d

Ensembl ID : ENSG00000105464
Gene: GRIN2D
Gene Synonyms: EB11,GLUN2D,NMDAR2D,NR2D
20 APIs:
18 Enzyme and pathways 8 Cross references
280 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Glutamate Ionotropic Receptor Nmda Type Subunit 3a

Ensembl ID : ENSG00000198785
Gene: GRIN3A
Gene Synonyms: GLUN3A
20 APIs:
5 Enzyme and pathways 7 Cross references
245 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Glutamate Ionotropic Receptor Nmda Type Subunit 3b

Ensembl ID : ENSG00000116032
Gene: GRIN3B
Gene Synonyms: GLUN3B
20 APIs:
5 Enzyme and pathways 7 Cross references
289 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Glutamate Ionotropic Receptor Kainate Type Subunit 1

Ensembl ID : ENSG00000171189
Gene: GRIK1
Gene Synonyms: GLUK1,GLUR5
4 APIs:
7 Enzyme and pathways 7 Cross references
316 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Glutamate Ionotropic Receptor Kainate Type Subunit 2

Ensembl ID : ENSG00000164418
Gene: GRIK2
Gene Synonyms: GLUK2,GLUR6,MRT6
3 APIs:
7 Enzyme and pathways 8 Cross references
333 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Glutamate Ionotropic Receptor Kainate Type Subunit 3

Ensembl ID : ENSG00000163873
Gene: GRIK3
Gene Synonyms: GLUK3,GLUR7
3 APIs:
7 Enzyme and pathways 7 Cross references
257 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Glutamate Ionotropic Receptor Kainate Type Subunit 4

Ensembl ID : ENSG00000149403
Gene: GRIK4
Gene Synonyms: GLUK4,GRIK,KA1
3 APIs:
6 Enzyme and pathways 8 Cross references
263 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Glutamate Ionotropic Receptor Kainate Type Subunit 5

Ensembl ID : ENSG00000105737
Gene: GRIK5
Gene Synonyms: GLUK5,GRIK2,KA2
3 APIs:
6 Enzyme and pathways 7 Cross references
302 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Glutamate Metabotropic Receptor 2

Ensembl ID : ENSG00000164082
Gene: GRM2
Gene Synonyms: GPRC1B,MGLU2,MGLUR2
6 APIs:
6 Enzyme and pathways 7 Cross references
281 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Glutamate Metabotropic Receptor 3

Ensembl ID : ENSG00000198822
Gene: GRM3
Gene Synonyms: GPRC1C,MGLU3,MGLUR3
4 APIs:
6 Enzyme and pathways 7 Cross references
213 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSG00000124493
Gene: GRM4
Gene Synonyms: GPRC1D,MGLU4,MGLUR4
1 APIs:
9 Enzyme and pathways 7 Cross references
266 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).